Celecoxib-Mepha Teva 100 mg

Celecoxib-Mepha Teva 100 mg is a medicine authorised by Swissmedic under authorisation number 69355. The authorisation holder is Mepha Pharma AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 06 May 2025 and the authorisation is limited until 05 May 2030. ATC code M01AH01 places the medicine in the group Anti-inflammatory and antirheumatic products.

  • Dispensing category B
  • Authorisation number 69355
  • ATC M01AH01
  • Synthetic medicines
Authorisation data
Authorisation number69355
NameCelecoxib-Mepha Teva 100 mg
Full nameCelecoxib-Mepha Teva 100 mg, Hartkapseln
Authorisation holderMepha Pharma AG
Medicinal product codeSynthetic medicines
Dispensing categoryB · Prescription only
ATC codeM01AH01
First authorisation06 May 2025
Authorisation validity05 May 2030
Strengths
No.NameDispensing categoryAuthorisation date
1Celecoxib-Mepha Teva 100 mg, HartkapselnB06 May 2025
2Celecoxib-Mepha Teva 200 mg, HartkapselnB06 May 2025

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
130Kapsel(n)M01AH0107.10.1.B
230Kapsel(n)M01AH0107.10.1.B
3100Kapsel(n)M01AH0107.10.1.B

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

Frequently asked questions

Is Celecoxib-Mepha Teva 100 mg authorised in Switzerland?

Yes. Celecoxib-Mepha Teva 100 mg is authorised by Swissmedic under authorisation number 69355, data as of 01 September 2026. The authorisation is limited until 05 May 2030.

Which dispensing category does Celecoxib-Mepha Teva 100 mg have?

Celecoxib-Mepha Teva 100 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.

Who is the authorisation holder of Celecoxib-Mepha Teva 100 mg?

The authorisation holder is Mepha Pharma AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com